Insider trade

Treace Medical Concepts (TMCI): CFO had shares withheld for tax 8,719 shares

Mark Hair, CFO at Treace Medical Concepts, reported a tax withholding of 8,719 shares.

8,719
Shares
Traded
Jan 10, 2026
Filed
Jan 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 16, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 4 more items)

What came next

  1. Jan 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Feb 27, 2026Company filing · Form 8-K · ResultsReported its results
  3. Apr 8, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“Effective as of the close of business on April 8, 2026, Gaetano M. Guglielmino, Chief Commercial Officer of Treace Medical Concepts, Inc. (the “Company”), will depart from the Company.”
  4. May 8, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Treace Medical Concepts

For Treace Medical Concepts, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMCI page.

How this filing works

Explore the data

Common questions

Which Treace Medical Concepts (TMCI) insider traded, and how much?

Mark Hair, CFO at Treace Medical Concepts, reported a tax withholding of 8,719 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Jan 10, 2026. Filed: Jan 14, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Treace Medical Concepts recently?

For Treace Medical Concepts, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the TMCI page.

Does this mean TMCI stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Treace Medical Concepts

Everything OQRO holds on this company is on its TMCI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data